Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathways

This publication has 72 references indexed in Scilit:

• Therapeutic effects of hAMSCs secretome on proliferation of MDA-MB-231 breast cancer cells by the cell cycle arrest in G1/S phase
  Clinical and Translational Oncology, 2023
• The Antitumor Activity of hAMSCs Secretome in HT-29 Colon Cancer Cells Through Downregulation of EGFR/c-Src/IRTKS Expression and p38/ERK1/2 Phosphorylation
  Cell Biochemistry and Biophysics, 2022
• The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/Stat3 signaling
  Medical Oncology, 2022
• Evaluating the effect of secretome of human amniotic mesenchymal stromal cells on apoptosis induction and epithelial‐mesenchymal transition inhibition in LNCaP prostate cancer cells based on 2D and 3D cell culture models
  Cell Biochemistry and Function, 2021
• Effects of Mesenchymal Stem Cell‐Derived Paracrine Signals and Their Delivery Strategies
  Advanced Healthcare Materials, 2021
• Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses
  Cellular and Molecular Life Sciences, 2020
• Stem cells as drug delivery methods: Application of stem cell secretome for regeneration
  Advanced Drug Delivery Reviews, 2015
• The secretome in cancer progression
  Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2013
• Oncostatin M promotes mesenchymal stem cell-stimulated tumor growth through a paracrine mechanism involving periostin and TGFBI
  The International Journal of Biochemistry & Cell Biology, 2013
• Updates on stem cells and their applications in regenerative medicine
  Journal of Tissue Engineering and Regenerative Medicine, 2008